A medical AI startup in Omaha, Neb., has received the FDA’s blessing to market software for diagnosing prostate cancer on MRI scans.

MRI technologists serving patients who have difficulty understanding English may need to budget additional scanner time—especially when image quality largely depends on patients’ compliance with breathing instructions.

“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.

Implementing an EHR cancer tracking system to review radiology reports for abnormal findings resulted in patients at one Veterans Affairs Hospital receiving their cancer diagnosis and treatment months earlier than those who were imaged before the system was put into place.

Point-of-care MRI is a worthwhile diagnostic option for emergency departments and ICUs concerned about wait or transport times to access fixed MRI for patients with neuroimaging needs.

Unrecognized imaging findings are an unfortunate, but undeniable, part of radiology. New advancements in artificial intelligence (AI) and machine learning offer a critical safety net that is improving care and saving lives — as well as avoiding millions of dollars in potential medical malpractice costs.

Patients who receive physical therapy for low back pain within two weeks of symptom onset pay significantly smaller healthcare bills at the 30-day and one-year marks than patients who wait longer for PT or never receive it.